Furthermore, the Akt/mTOR signaling pathway is frequently altered in certain types of cancer, including gastric cancer, prostate cancer, cervical carcinoma, renal cell carcinoma, lung carcinoma and pancreatic ductal adenocarcinoma (21–25). This evidence concerns the gene AKT1 and Familial prostate cancer.